The CHC’s mission is to promote and protect the benefit, for society and individual patient care, of the free flow of healthcare information.
Avanir Pharmaceuticals Inc. has appointed Rohan Palekar as president and CEO. Palekar joined Avanir in March 2012 as senior VP and chief commercial officer, and was promoted to executive […]
Mary Szela has been made CEO of Aegerion Pharmaceuticals Inc. Szela is also now a member of Aegerion’s board of directors. Executives say Szela brings 27 years of progressive […]
Yutaka Niihara, M.D., MPH, has been reapppointed CEO of Emmaus Life Sciences Inc. Dr. Niihara is co-founder and chairman of the company. Emmaus Life Sciences is engaged in the discovery, development and commercialization of innovative treatments and therapies for rare and orphan diseases.
FOSTER CITY, Calif.–(BUSINESS WIRE)–Gilead Sciences, Inc. (Nasdaq:GILD) today announced that, effective March 10, 2016, current Chairman and CEO John C. Martin, PhD will assume the role of Executive Chairman of […]
Company to focus on pipeline of Pentarins™ as a unique and promising approach to treating solid tumor cancers Lead drug candidate PEN-221 targeting neuroendocrine and small cell lung cancers to […]
Addition of Biologic KRYSTEXXA® (pegloticase) Expands and Diversifies Horizon’s Orphan Business; Leverages Rheumatology Expertise and Infrastructure; Transaction Is Expected to Be Immediately Accretive to Adjusted EBITDA in 2016; Conference Call […]
Many a blog, article, and cover story has focused on the impact (current and future) of healthcare reform. But some interesting healthcare industry changes have been occurring simultaneously with, and are very much accelerated by, the impact of reform. One of these important market changes is the shift from traditional silos of key customer decision-making to a more blended approach to healthcare (and formulary) decision-making.
Bayer has appointed Habib Dable as president of Bayer HealthCare Pharmaceuticals, the U.S.-based division of the global company’s pharma business. Dable reports to Philip Blake, who assumed the role of head of region Americas for Bayer HealthCare Pharmaceuticals and continues leading U.S. corporate functions as senior Bayer rep in the United States, a position he has held since 2012.
Pharmaceutical and Biotechnology Companies Can Now Digitally Transform Therapeutic Innovation VELIZY-VILLACOUBLAY, France — November 16, 2015 — Dassault Systèmes (Euronext Paris: #13065, DSY.PA), the 3DEXPERIENCE Company, world leader in […]
